Valores de hemoglobina glucosilada en pacientes con pie diabético infectado
Contenido principal del artículo
Resumen
La diabetes mellitus tipo 2 y sus complicaciones son padecimientos encontrados frecuentemente en el Hospital Central Militar. Dichas complicaciones son resultado del descontrol metabólico crónico, el cual pue- de ser estimado mediante la medición de hemoglobina glucosilada A1cl en la sangre de estos pacientes. En un estudio prospectivo realizado en 36 pacientes, 18 hombres y 18 mujeres, se observó que el 94.4% de ellos tenía cifras de hemoglobina glucosilada A1c por arriba del límite re- comendado para la prevención de complicaciones de 8%; sin embargo, no existe relación entre dichos valores y otros parámetros clínicos de importancia como la elevación de la glucosa plasmática o con el tiempo de evolución de la diabetes mellitus tipo 2.
Detalles del artículo
Sección
Cómo citar
Referencias
Abraira CA, Colwell JA, Nuttali FQ, Nagel NJ, Comstock JP. Veterans affairs cooperative study on glycemic control and complications in type II diabetes (VACSDM) 1995; 18: 1113-1123.
American Diabetes Association. Position Statement: tesis of glycemia in diabetes. Diabetes Care 1999; 22: 77-84.
Apelquivst J, Larsson J, Ardagh CD. Long term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993; 213: 485-491.
Bridges RM Jr, Deitch EA. Diabetic foot infections. Pathophysiology and treatment. Surg Clin North Am. 1994; 74: 537-555.
Bunn F. Evaluation of glycosilated hemoglobin in diabetic patients. Diabetes 1981; 30: 613-616.
Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Eng J Med 1994; 331: 854-860.
DeFronzo RA, Reasner C. The diabetes control and complications trial study: implications for the diabetic foot. J Foot Ankle Surg 1994;331: 854-860.
Eneroth W, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int 1997; 18: 716-722.
Gastar B, Hirsch IB. The effects of improved glycemic control and complications in type 2 diabetes. Arch Intern Med 1998; 158: 134-140.
Gavin JR, Davidson MB, DeFronzo RA, Drash A, Gabbe SG. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
Goldstein DE. Is glycosilated hemoglobin clinically usefull? N Eng J Med 1984; 9: 384-385.
Grayson ML, Diabetic foot infections. Antimicrobial therapy. Infect Dis Clin North Am 1995; 9: 143-145.
Greenspan ES, Baxter JO. Endocrinología básica y clínica. De El Manual Moderno 1997: 671-680.
Kapplan NM. Two dilemmas of diabetes. Arch Intern Med 1991; 151: 1270-1272.
Kennedy J, Marimee J. Glycosilated serum protein and hemoglobin A1 levels to measure control of glycernia. Ann Int Med 1981; 51: 56-58.
Kenny SJ, Aubert RC, Geiss LS. Prevalence and incidence of non- insulin dependent diabetes. In Diabetes in America, 2nd edition. National Institutes of Health 1995: 47.
Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin: implications for diabetes screening and monitoring. Diabetes Care 1998; 21: 261-269.
Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-268.
Levin JE. Preventing amputation in the patient with diabetes. Diabetes Care 1995; 10: 1383-1392.
Lipsky BA, Pecoraro RE, Larson SA. Outpatient management of uncomplicated lower extremity infections in diabetic patients. Arch In- tern Med 1990; 150: 790-797.
Mancini L, Ruotolo V. Infection of the diabetic foot. Rays 1997; 22: 544-549.
McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care 1995; 18: 216-219.
Meigs JB, Nathan DM, Cupples A, Eilson PW, Singer DE. Tracking of glycated hemoglobin in the original cohort of the Framingham heart study. J Clin Epidemiol 1996; 49: 411-417.
Ohkubo Y, Kishikawa H, Araki E. Intensive insulin therapy prevents the progression of diabetic microvascular complications in japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990; 13: 513-521.
Peters AL, Davidosn MB, Schriger DL, Hasselbad V. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glyco- silated hemoglobin levels. JAMA 1996; 276: 1246-1252.
Rabhar S. An abnormal hemoglobin in red cells of diabetes. Clin Chem Act 1968; 22: 296-298.
Slovenkai MP. Foot problems in diabetes. Med Clin North Am 1998; 82: 940-971.
The diabetes control and complications trial research group. The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993; 329: 977-986.